These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 6297173)

  • 1. [Hormones and tumor therapy: the rational basis of endocrine therapy in breast cancer].
    Szepesi T; Schratter-Sehn AU
    Wien Klin Wochenschr; 1982 Sep; 94(17):459-63. PubMed ID: 6297173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Selection of patients with breast cancer with regard to endocrine therapy].
    Cikes M; Pettavel J
    Schweiz Med Wochenschr; 1977 Nov; 107(46):1645-55. PubMed ID: 199940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Steroid receptors in breast cancer.
    Desombre ER
    Monogr Pathol; 1984; (25):149-74. PubMed ID: 6377047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hormonal therapy of the advanced breast cancer ].
    Gürtler R; Matthes ML; Tanneberger S
    Arch Geschwulstforsch; 1982 May; 52(3):231-40. PubMed ID: 7125859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular Action and Clinical Relevance of Aromatase Inhibitors.
    Murphy MJ
    Oncologist; 1998; 3(2):129-130. PubMed ID: 10388095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Steroid hormone receptors as targets for the therapy of breast and prostate cancer--recent advances, mechanisms of resistance, and new approaches.
    Hoffmann J; Sommer A
    J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):191-200. PubMed ID: 15860262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical relevance of steroid hormone receptors.
    Gürtler R; Görlich M
    Arch Geschwulstforsch; 1985; 55(5):387-97. PubMed ID: 4062496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hormones and tumor therapy: current clinical status and future developments in endocrine therapy of breast cancer].
    Szepesi T; Schratter-Sehn AU
    Wien Klin Wochenschr; 1982 Sep; 94(17):463-9. PubMed ID: 6760557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Content of epidermal growth factor receptor in metastatic breast cancer: its role in endocrine sensitivity prediction.
    Nesković-Konstantinović ZB; Nikolić-Vukosavljević DB; Branković-Magić MV; Mitrovic LB; Spuzić I
    Neoplasma; 2000; 47(2):107-13. PubMed ID: 10985476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Estrogen receptor Beta isoforms -- functions and clinical relevance in breast cancer].
    Mitter D; Ortmann O; Treeck O
    Zentralbl Gynakol; 2005 Aug; 127(4):228-34. PubMed ID: 16037904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Steroid hormone receptors in the management of human breast cancer.
    Knight WA; Osborne CK; Yochmowitz MG; McGuire WL
    Ann Clin Res; 1980 Oct; 12(5):202-7. PubMed ID: 7015982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic factors and response to therapy in breast cancer.
    Klijn JG; Berns EM; Foekens JA
    Cancer Surv; 1993; 18():165-98. PubMed ID: 8012996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neoadjuvant endocrine therapy for breast cancer: medical perspectives.
    Ellis MJ
    Clin Cancer Res; 2001 Dec; 7(12 Suppl):4388s-4391s; discussion 4411s-4412s. PubMed ID: 11916229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A proposed model for the prediction of response to endocrine therapy in breast cancer from the estrogen receptor status of one site and the number of metastatic sites.
    DeWys WD; Allegra JC; Simon R; Lippman MB
    Cancer Res; 1980 Jul; 40(7):2423-7. PubMed ID: 7388801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hormone receptors and breast cancer].
    Delarue JC
    Pathol Biol (Paris); 1976 Sep; 24(7):449-50. PubMed ID: 185573
    [No Abstract]   [Full Text] [Related]  

  • 16. Current status of adjuvant endocrine therapy for breast cancer.
    Ingle JN
    Clin Cancer Res; 2001 Dec; 7(12 Suppl):4392s-4396s; discussion 4411s-4412s. PubMed ID: 11916230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Breast cancer and neoadjuvant therapy: any predictive marker?
    Vyzula R; Dusek L; Zaloudík J; Demlová R; Klimes D; Selvekerová S
    Neoplasma; 2004; 51(6):471-80. PubMed ID: 15640958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The association between Akt activation and resistance to hormone therapy in metastatic breast cancer.
    Tokunaga E; Kataoka A; Kimura Y; Oki E; Mashino K; Nishida K; Koga T; Morita M; Kakeji Y; Baba H; Ohno S; Maehara Y
    Eur J Cancer; 2006 Mar; 42(5):629-35. PubMed ID: 16464571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Place of hormone receptor determination in the therapeutic strategy of breast cancer].
    Clavel B; Gest J
    Pathol Biol (Paris); 1983 Dec; 31(10):809-18. PubMed ID: 6366702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular basis of steroid hormone action in breast cancer and its clinical implications.
    Lunenfeld B; Geier A
    Isr J Med Sci; 1981; 17(9-10):954-9. PubMed ID: 7031015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.